Bezdicek Matej, Lengerova Martina, Ricna Dita, Weinbergerova Barbora, Kocmanova Iva, Volfova Pavlina, Drgona Lubos, Poczova Miroslava, Mayer Jiri, Racil Zdenek
Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Med Mycol. 2016 Oct 1;54(7):714-24. doi: 10.1093/mmy/myw032. Epub 2016 May 9.
Despite advances in the treatment of invasive fungal diseases (IFD), mortality rates remain high. Moreover, due to the expanding spectrum of causative agents, fast and accurate pathogen identification is necessary. We designed a panfungal polymerase chain reaction (PCR), which targets the highly variable ITS2 region of rDNA genes and uses high resolution melting analysis (HRM) for subsequent species identification. The sensitivity and specificity of this method was tested on a broad spectrum of the most clinically important fungal pathogens including Aspergillus spp., Candida spp. and mucormycetes. Despite the fact that fluid from bronchoalveolar lavage (BAL) is one of the most frequently tested materials there is a lack of literature sources aimed at panfungal PCR as an IFD diagnostic tool from BAL samples. The applicability of this method in routine practice was evaluated on 104 BAL samples from immunocompromised patients. Due to high ITS region variability, we obtained divergent melting peaks for different fungal species. Thirteen out of 18 patients with proven or probable IFD were positive. Therefore, the sensitivity, specificity, positive predictive value and negative predictive value of our method were 67%, 100%, 100%, and 94%, respectively. In our assay, fungal pathogens identification is based on HRM, therefore omitting the expensive and time consuming sequencing step. With the high specificity, positive and negative predictive values, short time needed to obtain a result, and low price, the presented assay is intended to be used as a quick screening method for patients at risk of IFD.
尽管侵袭性真菌病(IFD)的治疗取得了进展,但死亡率仍然很高。此外,由于致病原的范围不断扩大,快速准确的病原体鉴定是必要的。我们设计了一种泛真菌聚合酶链反应(PCR),其靶向rDNA基因高度可变的ITS2区域,并使用高分辨率熔解分析(HRM)进行后续的菌种鉴定。该方法的敏感性和特异性在包括曲霉属、念珠菌属和毛霉菌在内的一系列临床上最重要的真菌病原体上进行了测试。尽管支气管肺泡灌洗(BAL)液是最常检测的材料之一,但缺乏将泛真菌PCR作为BAL样本IFD诊断工具的文献来源。在104份来自免疫受损患者的BAL样本上评估了该方法在常规实践中的适用性。由于ITS区域的高度变异性,我们获得了不同真菌菌种的不同熔解峰。18例确诊或可能患有IFD的患者中有13例呈阳性。因此,我们方法的敏感性、特异性、阳性预测值和阴性预测值分别为67%、100%、100%和94%。在我们的检测中,真菌病原体鉴定基于HRM,因此省略了昂贵且耗时的测序步骤。鉴于其高特异性、阳性和阴性预测值、获得结果所需时间短以及价格低廉,本检测旨在用作IFD高危患者的快速筛查方法。